Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
about
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinomaDownregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinomaThe transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasisGenomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma.Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro studyCoronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validationAntiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.Oncolytic measles virus enhances antitumour responses of adoptive CD8+NKG2D+ cells in hepatocellular carcinoma treatment.Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell.Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy.Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.N-glycoproteome analysis of the secretome of human metastatic hepatocellular carcinoma cell lines combining hydrazide chemistry, HILIC enrichment and mass spectrometryGenomic aberrations in the HTPAP promoter affect tumor metastasis and clinical prognosis of hepatocellular carcinoma.Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinomaCoexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinomaEstablishment of monoclonal HCC cell lines with organ site-specific tropismsThe scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)Novel roles of TMEM100: inhibition metastasis and proliferation of hepatocellular carcinoma.Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like propertiesCXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.Elevated Src expression associated with hepatocellular carcinoma metastasis in northern Chinese patientsEstablishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells.MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasismiR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma.miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinomaClinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.Establishment of NOD/SCID mouse models of human hepatocellular carcinoma via subcutaneous transplantation of histologically intact tumor tissueOsteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentinSYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines.In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinomaExpression of X-linked inhibitor-of-apoptosis protein in hepatocellular carcinoma promotes metastasis and tumor recurrence.
P2860
Q21260408-07553089-DD33-40BE-96B3-F5CFCE5B092CQ24336278-41B95DC3-62D1-4C73-A334-45AEE0ADA678Q28543071-D2179593-B0F8-419D-B7F6-586C47860174Q33399464-A7CA9D8F-D6FD-4404-9B28-126042655901Q33495790-4E868CEF-750F-43F5-A44C-3504CA02E303Q33751830-AD4E08F7-C769-42A3-ABA2-AE0B4D3107CEQ33798661-E72E666E-B9DF-4E39-B924-1D4D5A1FDAC3Q33899522-40667818-3A57-4C8C-BDA6-0142B65F0E3DQ34178532-AD7EF7A0-8683-496D-B19C-DA662C69FA34Q34328740-F32ADDAA-3A44-499F-B018-A41D4B7BEC36Q34483637-922C34CB-C737-4047-9367-C52B76BB98E3Q34503882-D41486B5-F1C9-4750-A401-341F65D1275BQ34611324-E6017496-B5C4-4539-B448-D344AED5DBE8Q34634386-3207F923-5AAA-4C1D-9B16-01AED986C076Q35007692-09CCBF47-2452-41FE-BD53-BDFEA6E4DC5DQ35064045-1D462091-3C1B-488D-B527-200DAF4376E0Q35112679-CE200B86-0113-4281-A253-2B054EB53011Q35116051-5004A2C5-7AC7-4DB8-894A-2B6EDD44D95CQ35176162-A717384A-635D-4FDA-AE06-A843DD06AEFEQ35225695-4A73D2AA-7E9D-4C0B-99E9-90846DB3B318Q35781367-EC344F35-5CDC-431B-9B36-4E5D70E6FC81Q35803956-F790AAC8-C1D8-481E-A4BF-227251A56C94Q36152438-4B33B23C-611F-4827-9906-CC1566251B54Q36232052-AABDD6BD-77B7-4E8D-BC50-07D66919AAB0Q36267648-DB16985E-CA94-4172-B400-54F9C2F3CFC9Q36291113-582B7AA5-1648-4EA3-A822-EAC4557D7B52Q36334512-0248FD36-26A0-4DEA-B68C-5163B57E046BQ36492681-9B8E7DAD-DE88-4484-86B4-09DA4FDA6122Q36560489-F69EBD9F-E7A8-4B92-BCEA-8FAC020CFAA2Q36580396-B6BFDC13-FEBE-420D-B9C6-F1DE39573496Q36750072-A812F777-1F2B-402D-A308-16BB16C4C3B0Q36771909-229366A6-6CE1-4725-80E6-AE24408C52CAQ36846983-74634A63-7D5D-4AEC-891F-156D070DFD4EQ36967467-6D4488B9-9593-44BA-BD3D-7C0F16590168Q37022356-8DE05321-1E3A-4DBD-A300-6506DAFE1C85Q37113106-08142AD6-A91E-431D-A676-428926BD9592Q37115310-8CE67802-003C-4A06-9841-3827B32593DBQ37225469-47238E23-53BA-4327-9DED-77F1239B074DQ37349092-92AC4055-26C8-4AA6-8D05-AE4D8F73C093Q37402206-C84CDDBE-08A1-49E9-9D10-5741DE9CF34C
P2860
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Stepwise metastatic human hepa ...... on metastatic characteristics.
@en
type
label
Stepwise metastatic human hepa ...... on metastatic characteristics.
@en
prefLabel
Stepwise metastatic human hepa ...... on metastatic characteristics.
@en
P2093
P4510
P1476
Stepwise metastatic human hepa ...... on metastatic characteristics.
@en
P2093
Jiong Yang
Sheng-Long Ye
Yin-Kun Liu
Zhao-You Tang
P2888
P304
P356
10.1007/S00432-004-0564-9
P577
2004-05-14T00:00:00Z